Niki BioSolutions, Inc. (NIKI) Cash & Current Investments (2017 - 2025)

Niki BioSolutions (NIKI) has 9 years of Cash & Current Investments data on file, last reported at $84890.0 in Q4 2025.

• Quarterly Cash & Current Investments changed N/A year-over-year to $84890.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $84890.0 (changed N/A YoY) and the FY2025 annual result came in at $3.5 million, up 71.82% from the prior year.
• Cash & Current Investments improved to $84890.0 in Q4 2025, from $28313.0 in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $20.8 million in Q2 2021 to a low of $28313.0 in Q3 2025.
• A 5-year average of $4.9 million and a median of $3.2 million in 2022 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2021 — Cash & Current Investments surged 369.19% — and 2022, when it tumbled 79.68%.
• Tracing NIKI's Cash & Current Investments over 5 years: stood at $8.4 million in 2021, then dropped by 2.96% to $8.1 million in 2022, then slumped by 74.12% to $2.1 million in 2023, then plunged by 96.67% to $70276.0 in 2024, then gained by 20.8% to $84890.0 in 2025.
• The last three Cash & Current Investments figures came in at $84890.0 (Q4 2025), $28313.0 (Q3 2025), and $56836.0 (Q2 2025), per Business Quant data.